MALVERN, PA — Ocugen, Inc. (Nasdaq: OCGN) announced it has completed enrollment for the Phase 3 liMeliGhT clinical trial evaluating OCU400, a gene therapy candidate for retinitis pigmentosa, a group ...

Alterity Therapeutics has appointed internationally recognised expert in neurodegenerative diseases Daniel O Claassen as chief medical advisor. ... Read More The post Alterity bolsters clinical ...

Multivitamins are the most common dietary supplement in the U.S. People take these pills (or gummies, indeed) for a variety of health reasons, but the science on what multivitamins may do for your ...

DT Research will showcase the DT574 medical-grade All-in-One (AIO) computer and the WebDT Battery Fleet Manager at the HIMSS 2026 Global Health Conference and Exhibition in booth 1964, March 10-12, in ...

Positive data from EXPERTS-ALS could accelerate RT1999 towards a registration trial; RT1999 to be presented as a poster ...

Diabetes and obesity drugs also lead to large reductions in adverse cardiovascular events, and the benefits aren’t just down ...

X-TOLE2 met primary endpoint in both dose groups, including -53.2% median percent change (MPC) from baseline in monthly FOS frequency with 25 mg ...

Collagen supplements may improve skin and reduce osteoarthritis pain, but new research finds little evidence for workout or recovery benefits.

Camp4 Therapeutics FY25 GAAP EPS missed expectations, but ended the year with a robust cash position. Check out why CAMP ...

China's BCI market estimated to reach $809 million by 2027 China expanding clinical trials, state support for BCIs Aims to close gap between research, industry and clinic BEIJING, March 8 (Reuters) - ...

A growing body of research has looked at GLP-1 drugs for alcohol use disorder. A new study shows the medications could have a ...

In teenagehood, some degree of irritability comes with the territory. But severe emotional disorders in teens could be exacerbated by something as seemingly innocuous as a gap in their diet.